Drug Discovery & Research
AbbVie Bets $710 Million on AI-Designed Drugs as Nvidia-Backed Startup Eyes Public Markets
Iambic Therapeutics secures pharma giant partnership and files for IPO in same-day move that tests whether artificial intelligence can deliver on drug discovery promises.
Health AI Central Editorial Team·September 24, 2026